Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 4Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 4Lymphoid 1Gastrointestinal 1

Conditions

Thrombocytopenia 3Lymphoma 1Chemotherapy-induced Thrombocytopenia 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × avatrombopag × Clear all
NCT05218226 2025-02-24

Avatrombopag for Chemotherapy-induced Thrombocytopenia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Unknown
50 enrolled
Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT06001567 2023-09-14

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Second Affiliated Hospital of Guangzhou Medical University

Phase 2 Unknown
30 enrolled
Classical hematologyGastrointestinal

Carcinoma, Hepatocellular, Thrombocytopenia

NCT04896528 2021-05-21

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Peking Union Medical College Hospital

Phase 2 Unknown
30 enrolled
Classical hematology

Thrombocytopenia

NCT04797182 2021-03-15

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Sun Yat-sen University

Phase 2 Unknown
46 enrolled
Classical hematologyLymphoid

Lymphoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡